Jennifer Silva discusses the importance of discussing black box warnings when utilizing JAK inhibitors in patients with vitiligo.
Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo
Jennifer Silva discusses the importance of discussing black box warnings when utilizing JAK inhibitors in patients with vitiligo.
PLAY
Julien Seneschal, MD, PhD: An Update on Topical and Systemic JAK Inhibition for Vitiligo
Dr. Seneschal discusses currently available topical JAKs for vitiligo, systemic JAKs being trialed to treat the condition in the future, and how JAKs can be...
PLAY
Jennifer Silva, APRN-DNP: Providing Adequate Treatment for Patients with Vitiligo
Jennifer Silva discusses a few treatment strategies to utilize in patients who continue to struggle to find effective treatment for their vitiligo.
PLAY
Iltefat Hamzavi, MD: Combining Phototherapy with Topical Therapy in Patients with Vitiligo
Iltefat Hamzavi, MD, and JCAD’s Editor-in-Chief, James Del Rosso, DO, discuss topical treatment considerations for patients with vitiligo when using topical ruxolitinib cream, including topical...
PLAY
Gina Mangin, MPAS, PA-C: Coaching Pearls for Patients with Vitiligo
Gina Mangin discusses effective treatment practice for patients with vitiligo centered around providing encouragement and motivation throughout the process.
PLAY
David Rosmarin, MD: Updates in Topical and Systemic Vitiligo Treatment
Dr. Rosmarin discusses his vitiligo session from November’s Masterclasses in Dermatology Meeting, in which he reviewed recent insights on maintaining and building upon initial treatment...
PLAY